1. Home
  2. Live Updates
  3. Institutional investors weigh in on galmed pharmaceuticals

Live Breaking News & Updates on Institutional Investors Weigh In On Galmed Pharmaceuticals

Stay updated with breaking news from Institutional investors weigh in on galmed pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at StockNews.com

Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Institutional Investors Weigh In On Galmed Pharmaceuticals , Raymond James Financial Services Advisors Inc , Galmed Pharmaceuticals , Galmed Pharmaceuticals Ltd , Walleye Capital , Galmed Pharmaceuticals Price Performance , Cambridge Investment Research Advisors Inc , News Ratings For Galmed Pharmaceuticals Daily , Millennium Management , Get Free Report , Investment Research Advisors , James Financial Services Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily ,

StockNews.com Begins Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)

StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD stock opened at $0.46 on Tuesday. The firm has a market cap of $764,400.00, a price-to-earnings ratio of -0.12 and […] ....

United Kingdom , Institutional Investors Weigh In On Galmed Pharmaceuticals , Millennium Management , Galmed Pharmaceuticals Stock Performance , Galmed Pharmaceuticals Ltd , Raymond James Financial Services Advisors Inc , Walleye Capital , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals , Cambridge Investment Research Advisors Inc , Free Report , Get Free Report , James Financial Services Advisors , Investment Research Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.35 on Friday. The stock has a market cap of $586,488.00, a PE ratio of -0.09 […] ....

United Kingdom , Raymond James Financial Services Advisors Inc , Institutional Investors Weigh In On Galmed Pharmaceuticals , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals , Millennium Management , Walleye Capital , Galmed Pharmaceuticals Ltd , Cambridge Investment Research Advisors Inc , Galmed Pharmaceuticals Stock Performance , Free Report , Investment Research Advisors , James Financial Services Advisors , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)

StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $0.39 on Friday. The firm has a market cap of $648,480.00, a PE ratio of […] ....

United Kingdom , Galmed Pharmaceuticals , Galmed Pharmaceuticals Stock Performance , News Ratings For Galmed Pharmaceuticals Daily , Millennium Management , Walleye Capital , Galmed Pharmaceuticals Ltd , Cambridge Investment Research Advisors Inc , Institutional Investors Weigh In On Galmed Pharmaceuticals , Raymond James Financial Services Advisors Inc , Free Report , James Financial Services Advisors , Cambridge Investment Research Advisors , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Short Interest Update

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 11,200 shares, an increase of 75.0% from the September 30th total of 6,400 shares. Approximately 0.3% of the shares of the stock are short sold. Based […] ....

United Kingdom , Millennium Management , Galmed Pharmaceuticals , Cambridge Investment Research Advisors Inc , Galmed Pharmaceuticals Stock Performance , News Ratings For Galmed Pharmaceuticals Daily , Maxim Group , Institutional Investors Weigh In On Galmed Pharmaceuticals , Galmed Pharmaceuticals Ltd , Raymond James Financial Services Advisors Inc , Get Free Report , Investment Research Advisors , Raymond James Financial Services Advisors , James Financial Services Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd ,